CLRB
Cellectar Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.41
+1.69%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+1.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 10, 2026 | Loren Stefan · other: Consultant | A-Award | 15,000 | $2.69 |
| Jul 8, 2026 | DRISCOLL FREDERICK W · director | A-Award | 25,000 | $2.70 |
| Jul 8, 2026 | Chanan-Khan Asher · director | A-Award | 25,000 | $2.70 |
| Jul 8, 2026 | CARUSO JAMES V · director, officer: President & CEO | A-Award | 250,000 | $3.14 |
| Jul 8, 2026 | Gu Andrew · director | A-Award | 25,000 | $2.70 |
| Jul 8, 2026 | Kolean Chad J · officer: CFO | A-Award | 92,000 | $3.14 |
| Jul 8, 2026 | Loren Stefan · other: Consultant | A-Award | 15,000 | $2.68 |
| Jul 8, 2026 | NEIS JOHN · director | A-Award | 25,000 | $2.70 |
| Jul 8, 2026 | Swirsky Douglas J · director | A-Award | 37,500 | $2.70 |
| Jul 8, 2026 | Longcor Jarrod · officer: Chief Operating Officer | A-Award | 118,000 | $3.14 |
| May 11, 2026 | CARUSO JAMES V · director, officer: Chief Executive Officer | Purchase | 26,040 | $2.88 |
| May 11, 2026 | Longcor Jarrod · officer: Chief Operating Officer | Purchase | 8,680 | $2.88 |
| May 11, 2026 | Longcor Jarrod · officer: Chief Operating Officer | Purchase | 26,040 | $2.88 |
| May 11, 2026 | CARUSO JAMES V · director, officer: Chief Executive Officer | Purchase | 8,680 | $2.88 |
| Dec 16, 2025 | NEIS JOHN · director | Sale | 198 | $3.70 |
| Jul 3, 2025 | Kolean Chad J · officer: Chief Financial Officer | Purchase | 5,000 | $4.99 |
| Jul 3, 2025 | CARUSO JAMES V · director, officer: Chief Executive Officer | Purchase | 10,000 | $4.99 |
| Jul 3, 2025 | Longcor Jarrod · officer: Chief Operating Officer | Purchase | 10,000 | $4.99 |
| Mar 12, 2025 | Longcor Jarrod · officer: Chief Operating Officer | Purchase | 30,000 | $0.28 |
| Feb 18, 2025 | Kolean Chad J · officer: Chief Financial Officer | A-Award | 290,000 | $0.29 |
| Feb 18, 2025 | DRISCOLL FREDERICK W · director | A-Award | 60,000 | $0.29 |
| Feb 18, 2025 | Chanan-Khan Asher · director | A-Award | 60,000 | $0.29 |
| Feb 18, 2025 | CARUSO JAMES V · director, officer: President and CEO | A-Award | 900,000 | $0.29 |
| Feb 18, 2025 | Longcor Jarrod · officer: Chief Operating Officer | A-Award | 500,000 | $0.29 |
| Feb 18, 2025 | Loren Stefan · director | A-Award | 60,000 | $0.29 |
| Feb 18, 2025 | NEIS JOHN · director | A-Award | 60,000 | $0.29 |
| Feb 18, 2025 | Swirsky Douglas J · director | A-Award | 90,000 | $0.29 |
| Jun 18, 2024 | Loren Stefan · director | A-Award | 60,000 | $2.58 |
| Jun 18, 2024 | Swirsky Douglas J · director | A-Award | 90,000 | $2.58 |
| Jun 18, 2024 | NEIS JOHN · director | A-Award | 60,000 | $2.58 |
Institutional positioning
13F filings over the trailing two quarters
New 18Increased 8Reduced 6Sold out 4
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Caligan Partners LP | New Position | 469,998 | Aug 14, 2026 |
| STEMPOINT CAPITAL LP | New Position | 354,938 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 327,367 | Aug 13, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | New Position | 321,728 | Aug 13, 2026 |
| Bleichroeder LP | Increased | 288,679 | Aug 13, 2026 |
| Jupiter Topco LLC | New Position | 274,156 | Aug 14, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | New Position | 220,000 | Aug 14, 2026 |
| Nantahala Capital Management, LLC | New Position | 219,998 | Aug 19, 2026 |
| Empery Asset Management, LP | New Position | 189,605 | Aug 11, 2026 |
| DIADEMA PARTNERS LP | New Position | 138,341 | Aug 14, 2026 |
| Stonepine Capital Management, LLC | New Position | 104,550 | Aug 17, 2026 |
| BLEICHROEDER LP | Unchanged | 100,000 | May 14, 2026 |
| Persistent Asset Partners Ltd | New Position | 92,983 | Aug 7, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | New Position | 85,069 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 81,884 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 10, 2026